White Lauren 4
4 · C4 Therapeutics, Inc. · Filed Feb 16, 2022
Insider Transaction Report
Form 4
White Lauren
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-02-14+100,000→ 100,000 totalExercise: $22.71Exp: 2032-02-13→ Common Stock (100,000 underlying) - Award
Performance Restricted Stock Units
2022-02-14+26,250→ 26,250 totalExp: 2025-02-28→ Common Stock (26,250 underlying)
Footnotes (2)
- [F1]The shares underlying this option shall vest and become exercisable in sixteen equal quarterly installments following the grant date, with the first installment vesting on May 14, 2022.
- [F2]Each performance restricted stock unit ("PRSU") represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. 4,500 PRSUs shall vest upon satisfaction of three escalating share price vesting milestones, and the remaining 21,750 PRSUs shall vest upon satisfaction of certain discovery and clinical milestones.